GlassScriptPhysician profile
Sofia J Selbka Salituro
NPI 1528174950
$1,101.00
in general payments reported to CMS, 2019-2025
15 companies · $118 in 2025
The $118 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.64 · 2021: $158 · 2022: $203 · 2023: $238 · 2024: $351 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $155.99 | 2022-2025 | Azstarys |
| Kaleo, INC. | $153.35 | 2022-2024 | Auvi-Q |
| Tris Pharma INC | $139.33 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Ironshore Pharmaceuticals INC. | $101.49 | 2024 | |
| Sanofi Pasteur INC. | $97.43 | 2023-2024 | |
| Baxter Healthcare | $94.08 | 2022 | |
| Welch Allyn | $94.08 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.59 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $45.59 | 2023-2025 | Vaxelis, Vaxneuvance, Rotateq |
| Noven Therapeutics, LLC | $42.18 | 2024 | Xelstrym |
| Sobi, INC | $36.57 | 2023 | |
| Collegium Pharmaceutical, INC. | $24.83 | 2025 | Jornay Pm |
| Alk-Abello, INC | $22.98 | 2025 | Neffy |
| Shire North American Group INC | $13.92 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Selbka Salituro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.